Yasuhiro Ohashi

Title: Yasuhiro Ohashi: Innovator in Herpesvirus Research

Introduction

Yasuhiro Ohashi is a notable inventor based in Noda, Japan. He has made significant contributions to the field of virology, particularly in the development of inhibitors for herpesviruses. With a total of 2 patents, his work has the potential to impact the treatment of viral infections.

Latest Patents

Ohashi's latest patents include an inhibitor of herpesvirus absorption, known as LEM. This innovative product is an aqueous extract derived from a mycelial culture of Lentinus edodes. The sugar composition of LEM includes arabinose, xylose, glucose, mannose, galactose, fucose, and rhamnose. Additionally, he has developed a fraction of LEM that corresponds to molecular weights ranging from 10,000 to 1,000,000 daltons, which also contains a sugar composition of arabinose, xylose, glucose, mannose, and galactose. These agents are designed to inhibit the adsorption of herpesviruses, such as herpes simplex, to cells. Furthermore, he has created an inhibitor of the proliferation of herpesviruses, which is an active material obtained through fractional purification of the aqueous extract from cultured Lentinus edodes mycelia. This invention aims to prevent the recurrence of affections caused by latent infections.

Career Highlights

Throughout his career, Yasuhiro Ohashi has worked with several companies, including Noda Shokukin Kogyo Co., Ltd. and JCR Pharmaceuticals Co., Ltd. His experience in these organizations has contributed to his expertise in the field of virology and patent development.

Collaborations

Ohashi has collaborated with notable colleagues, including Junichi Koga and Hajime Hiratani. These partnerships have likely enhanced his research and innovation efforts.

Conclusion

Yasuhiro Ohashi's contributions to herpesvirus research through his patents demonstrate his commitment to advancing medical science. His innovative work has the potential to provide new solutions for those affected by viral infections.